The diabetes medication that could revolutionise heart failure treatment

Published by  News Archive

On 1st Dec 2021

Blue and white pills falling onto a flat surface.

A medication originally used for patients with diabetes is the first to help people with heart failure and could revolutionise treatment, according to new research from the University of East Anglia.

Early research had shown that Sodium-glucose co-transporter-2 (SGLT2) inhibitors could help around half of heart failure patients – those with a condition known as reduction ejection fraction.

But new findings published today show that the medication could be beneficial for all heart failure patients – including those with a second type of heart failure called preserved ejection fraction.

It is the first drug to provide a real benefit in terms of improving outcomes for these patients. And the research team say it will revolutionise treatment options.

Lead researcher Prof Vass Vassiliou, from UEA’s Norwich Medical School and an Honorary Consultant Cardiologist at the Norfolk and Norwich University Hospital, said: “Heart failure is a condition where the heart is not pumping as well as it should, and it affects about one million people in the UK.

“There are two types of heart failure. Heart Failure with a reduction in ejection fraction happens when the heart is unable to pump blood round the body due to a mechanical issue. And heart failure with preserved ejection fraction happens when, despite the heart pumping out blood well, it is not sufficient to provide oxygen to all the parts of the body.

“Patients are equally split between the two types of heart failure.

“For many years there was not a single medicine that could improve the outcome in patients with the second type of heart failure – those patients with preserved ejection fraction.

“This type of heart failure had puzzled doctors, as every medicine tested showed no benefit.

“One class of heart medication, called SGLT2 inhibitors, was initially used for patients with diabetes. However, it was noticed that it also helped patients who had heart failure.

“Previous studies had shown that this medication would be beneficial in heart failure with reduced ejection fraction.

“But we found that it can also help heart failure patients with preserved ejection fraction.”

SGLT2 inhibitors are more commonly known under their trade-names Forxiga (Dapagliflozin), Invokana (Canagliflozin), and Jardiance (Empagliflozin).

The research team undertook a meta-analysis of all studies published in the field and brought together data from almost 10,000 patients. They used statistical modelling to show the specific effect of these medicines.

Prof Vassiliou said: “We found that patients taking SGLT2 inhibitors were 22 per cent less likely to die from heart-related causes or be hospitalised for heart failure exacerbation than those taking placebo.

“This is very important because this is the first medication that can provide a benefit to this previously untreatable group of patients - in terms of heart-related deaths or hospitalisation.

“This is the first medication that can really improve the outcomes for this patient group and it will revolutionise the treatment offered to heart failure patients,” he added.

This study was led by researchers at UEA in collaboration with the Norfolk and Norwich University Hospital, Imperial College London and Imperial College NHS Trust, and Cambridge University Hospitals.

‘Sodium Glucose Co-transporter 2 (SGLT2) inhibitors in Heart Failure with Preserved Ejection Fraction: A systematic review and meta-analysis’ is published in the European Journal of Preventive Cardiology on December 1, 2021.

Latest News

  News
A pregnant woman stands next to a window
17 Jan 2022

Helping new mums stay smoke free

UEA researchers are recruiting to a major new study to help new mums stay smoke free.

Read more >
  News
11 Jan 2022

Norwich Business School joins highly acclaimed Small Business Charter

The accolade is in recognition of its expertise in supporting small businesses, student entrepreneurship, and the local economy, with Norwich Business School at...

Read more >
  News
A selection of fruits and vegetables representing a Mediterranean diet.
10 Jan 2022

Could a Mediterranean diet be key to prevent dementia?

UEA researchers are launching a study to see whether the beneficial effects of a Mediterranean diet could help prevent dementia.

Read more >
  News
A woman at an outdoor group exercise class stretches her arms
07 Jan 2022

How exercise interventions could help people with asthma

Interventions aimed at promoting physical activity in people with asthma could improve their symptoms and quality of life – according to new UEA research.

Read more >
Are you searching for something?
  News
A woman at an outdoor group exercise class stretches her arms
07 Jan 2022

How exercise interventions could help people with asthma

Interventions aimed at promoting physical activity in people with asthma could improve their symptoms and quality of life – according to new UEA research.

Read more >
  News
Photograph of the US research ship Nathaniel B Palmer at the ice front of Thwaites Glacier
05 Jan 2022

UEA scientists lead new mission to Antarctica’s remote Thwaites Glacier

On the 100th anniversary of the polar explorer Sir Ernest Shackleton’s death, a research mission using a fleet of underwater robots to determine the impact of...

Read more >
  News
A man wears a headset device designed to help diagnose dizziness.
22 Dec 2021

£1.25 million funding boost for dizziness device

UEA researchers have been awarded £1.25 million to develop a device to help people with dizziness.

Read more >
  News
16 Dec 2021

Bestselling authors and inspirational thought leaders announced in UEA Live’s spring line-up

With headliners ranging from literary heavy hitters to up-and-coming social activists, and books that include memoir, political commentary, thriller and...

Read more >
  News
Cancelled flight information board at airport due to COID-19 pandemic
15 Dec 2021

Human cost of Covid travel restrictions revealed in new study

New research shows the high human costs and negative impacts of border closures and travel bans during the Covid pandemic for ‘transnational’ individuals and...

Read more >
  News
A view of the tents at a relief camp set up for those made homeless after an earthquake
14 Dec 2021

Study shows how news shapes humanitarian aid from governments

A new study shows that media coverage of crises can increase governments’ allocation of emergency humanitarian aid — whether or not the crisis merits it.

Read more >